Recombinant human endostatin (Star Lake Bioscience)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human endostatin (Star Lake Bioscience)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesStar Lake Bioscience Co Inc Zhaoqing Guangdong
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStar Lake Bioscience Co Inc Zhaoqing Guangdong
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A